Can This Healthcare Stock Keep Going After a Nearly 70% Surge?
Amneal Pharmaceuticals (AMRX) is trading at new 5-year highs with strong technical momentum. AMRX has gained 69% over the past year. Shares maintain a 100% “Buy” technical opinion on Barchart. Analyst sentiment is positive, with multiple “Strong Buy” ratings and price targets as high as $15. Today’s Featured Stock Valued...
Barchart ·
Barchart
Benzinga
